Abstract
Clinicians in hematology practice commonly encounter anemia, hypercalcemia and renal failure, which when present in combination evoke a diagnostic workup for multiple myeloma. We report a 71-years old lady who presented to our hematology clinic with fever and easy fatiguability of 3 months duration and on investigations was found to have anemia and hypercalcemia. Direct Coomb’s test characterized the anemia as complement mediated (anti-C3d) hemolysis. Biochemical investigations revealed normal 25(OH) Vitamin D3 and suppressed Parathormone levels and a negative workup for plasma cell dyscrasias, sarcoidosis and autoimmune disorders. CT scan revealed a paravertebral mass with cervical, supraclavicular and abdominal lymphadenopathy along with splenomegaly and left pleural effusion. Biopsy from the paravertebral mass confirmed the diagnosis of Hodgkin’s disease (nodular sclerosis) using immunohistochemistry. Bone marrow examination suggested infiltration by lymphoma. Hypercalcemia was managed with saline and zoledronic acid. Administration of prednisolone (1 mg/kg/day) along with chemotherapy (ABVD regimen) led to normalization of calcium and hemoglobin levels. However, hemolysis recurred 2 weeks later and hence, Rituximab (375 mg/m2) was administered on a weekly schedule for 4 doses and ABVD (2 weekly) was continued, which brought hemolysis under control. Co-occurrence of two paraneoplastic manifestations (complement mediated hemolytic anemia and hypercalcemia) in Hodgkin’s lymphoma is very unusual. Present report aims not only to highlight a rare presentation of Hodgkin’s lymphoma but also focus on the role of Rituximab in controlling hemolysis associated with this disease.
References
Eisner E, Ley AB, Mayer K (1967) Coomb’s-positive hemolytic anemia in Hodgkin’s disease. Ann Intern Med 66:258–273
Linde R, Basso L (1987) Hodgkin’s disease with hypercalcemia detected by thallium-201 scintigraphy. J Nucl Med 28:112–115
Levine AM, Thornton P, Forman SJ, Van Hale P, Holdorf D, Rouault CL, Powars D et al (1980) Positive Coombs test in Hodgkin’s disease: significance and implications. Blood 55:607–611
Seymour JF, Gagel RF (1993) Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin’s disease and non Hodgkin’s lymphomas. Blood 82:1383–1394
Giannopoulos P, Bergsagel DE (1959) The mechanism of the anemia associated with Hodgkin’s disease. Blood 14:856–869
Gellhorn A, Plimpton CH (1956) Hypercalcemia in malignant disease without evidence of bone destruction. Am J Med 21:750–759
Karmali R, Barker S, Hewison M, Fraher L, Katz DR, O’Riordan JL (1990) Intermittent hypercalcemia and vitamin D sensitivity in Hodgkin’s disease. Postgrad Med J 66:757–760
Adams JS (1989) Vitamin D metabolite-mediated hypercalcemia. Endocrinol Metab Clin N Am 18:765–778
Krakauer T, Oppenhaim JJ (1993) IL-1 and tumor necrosis factor α each up-regulate both the expression of IFN-γ receptors and enhance IFN-γ induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1). J Immunol 150:1205–1211
Adams ND, Gray RW, Lemann J Jr, Cheung HS (1982) Effects of calcitriol administration on calcium metabolism in healthy men. Kidney Int 21:90–97
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare no conflicts of interests.
Ethical statement
The authors declare that the manuscript submitted is in accordance with the ethical guidelines as under Helsinki Declaration 1976.
Consent for publication
The authors hereby declare that appropriate written and informed consent was obtained from the patient prior to publication of any material.
Rights and permissions
About this article
Cite this article
Jain, A., Malhotra, P., Prakash, G. et al. Rare Occurrence of 3 “H”: Hypercalcemia, Hemolytic Anemia and Hodgkin’s Lymphoma. Indian J Hematol Blood Transfus 32 (Suppl 1), 163–167 (2016). https://doi.org/10.1007/s12288-016-0672-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-016-0672-0